composto, uso de um composto, combinação, e, composição farmacêutica

The present invention relates to 6-5 membered fused pyridine ring compounds according to formula Ior a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 mem...

Full description

Saved in:
Bibliographic Details
Main Authors JOHANNES BERNARDUS MARIA REWINKEL, ADRIANUS PETRUS ANTONIUS MAN, ARTHUR A. OUBRIE, CHRISTIAAN GERARDUS JOHANNES MARIA JANS, JAN-GERARD STERRENBURG, JACOBUS C. H. M. WIJKMANS, TJEERD A. BARF, HANS C. A. RAAIJMAKERS
Format Patent
LanguagePortuguese
Published 21.02.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to 6-5 membered fused pyridine ring compounds according to formula Ior a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to formula I in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.
Bibliography:Application Number: BR20141101255